A detailed history of Vestmark Advisory Solutions, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 3,404 shares of EW stock, worth $230,655. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,404
Previous 6,258 45.61%
Holding current value
$230,655
Previous $578,000 61.25%
% of portfolio
0.01%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $170,383 - $267,648
-2,854 Reduced 45.61%
3,404 $224,000
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $69,800 - $78,088
-828 Reduced 11.69%
6,258 $578,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $18,280 - $24,081
252 Added 3.69%
7,086 $677,000
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $48,936 - $61,663
793 Added 13.13%
6,834 $521,000
Q3 2023

Nov 06, 2023

SELL
$69.28 - $93.38 $480,248 - $647,310
-6,932 Reduced 53.43%
6,041 $418,000
Q2 2023

Aug 07, 2023

BUY
$81.41 - $94.33 $144,991 - $168,001
1,781 Added 15.91%
12,973 $1.22 Million
Q1 2023

May 09, 2023

SELL
$74.26 - $84.51 $41,585 - $47,325
-560 Reduced 4.77%
11,192 $925,000
Q4 2022

Jan 20, 2023

SELL
$68.3 - $87.44 $1,366 - $1,748
-20 Reduced 0.17%
11,752 $0
Q3 2022

Nov 03, 2022

SELL
$82.37 - $107.29 $438,537 - $571,211
-5,324 Reduced 31.14%
11,772 $973,000
Q2 2022

Aug 04, 2022

BUY
$86.5 - $128.27 $263,738 - $391,095
3,049 Added 21.71%
17,096 $1.63 Million
Q1 2022

Apr 27, 2022

BUY
$101.96 - $128.34 $58,219 - $73,282
571 Added 4.24%
14,047 $1.65 Million
Q4 2021

Jan 31, 2022

BUY
$106.37 - $130.68 $77,756 - $95,527
731 Added 5.74%
13,476 $1.75 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $2,058 - $2,455
20 Added 0.16%
12,745 $1.44 Million
Q2 2021

Aug 09, 2021

BUY
$83.84 - $104.76 $35,464 - $44,313
423 Added 3.44%
12,725 $1.32 Million
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $474,519 - $546,830
6,031 Added 96.17%
12,302 $1.03 Million
Q4 2020

Feb 04, 2021

BUY
$71.69 - $91.23 $143 - $182
2 Added 0.03%
6,271 $572,000
Q3 2020

Oct 19, 2020

SELL
$67.19 - $87.44 $30,101 - $39,173
-448 Reduced 6.67%
6,269 $500,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $269,862 - $360,895
4,690 Added 231.38%
6,717 $464,000
Q1 2020

May 06, 2020

BUY
$52.41 - $81.0 $106,235 - $164,187
2,027 New
2,027 $382,000
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $146,411 - $167,627
-2,042 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$61.55 - $75.43 $16,310 - $19,988
-265 Reduced 11.49%
2,042 $449,000
Q2 2019

Aug 20, 2019

SELL
$55.74 - $64.41 $16,108 - $18,614
-289 Reduced 11.13%
2,307 $426,000
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $124,322 - $166,273
2,596 New
2,596 $497,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.